These studies have demonstrated an increase of PTX3 expression in GB patients and its ability to modulate several immune-infiltrating cells, including CD4+/CD8+ T cells, NK cells, macrophages, and DCs in the glioma microenvironment, suggesting its pivotal role. The gene discussed is PTX3; the disease is central nervous system cancer.